Search Results - Christopher Amos

Christopher Amos

Christopher Ian Amos is an American genetic epidemiologist and the director of the Institute for Clinical and Translational Research at Baylor College of Medicine, where he is also the associate director for quantitative science at the Dan L Duncan Comprehensive Cancer Center. He is known for his research on the genetic basis of certain types of human cancer. Provided by Wikipedia
  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    GELCC Phenotype Database: Familial Lung Cancer Data Across Families by Matthew Orchard, Colette Gaba, Erin Crawford, Christopher Amos, Uma Ramamurthy, James Willey

    Published in Translation (2023-12-01)
    Get full text
    Article


  2. 2

    Psychosocial and health behavioural impacts of COVID-19 pandemic on adults in the USA: protocol for a longitudinal cohort study by Xiaotao Zhang, Hoda Badr, Abiodun Oluyomi, Maral Adel Fahmideh, Syed Ahsan Raza, Ola El-Mubasher, Christopher Amos

    Published in BMJ Open (2020-12-01)
    Get full text
    Article


  3. 3

    P091: Variants at variance: An assessment of discordant classifications and phenotypes among TP53 variants from the international LiFT UP study by Alison Schwartz Levine, Bita Nehoray, Sophie Cahill, Aleck Cervantes, Megan Frone, Christopher Amos, Stephen Gruber, Judy Garber

    Published in Genetics in Medicine Open (2024-01-01)
    Get full text
    Article


  4. 4

    Common genetic variations in telomere length genes and lung cancer: a Mendelian randomisation study and its novel application in lung tumour transcriptome by Ricardo Cortez Cardoso Penha, Karl Smith-Byrne, Joshua R Atkins, Philip C Haycock, Siddhartha Kar, Veryan Codd, Nilesh J Samani, Christopher Nelson, Maja Milojevic, Aurélie AG Gabriel, Christopher Amos, Paul Brennan, Rayjean J Hung, Linda Kachuri, James D Mckay

    Published in eLife (2023-04-01)
    Get full text
    Article


  5. 5

    On the interplay of telomeres, nevi and the risk of melanoma. by Clara Bodelon, Ruth M Pfeiffer, Valentina Bollati, Julien Debbache, Donato Calista, Paola Ghiorzo, Maria Concetta Fargnoli, Giovanna Bianchi-Scarra, Ketty Peris, Mirjam Hoxha, Amy Hutchinson, Laurie Burdette, Laura Burke, Shenying Fang, Margaret A Tucker, Alisa M Goldstein, Jeffrey E Lee, Qingyi Wei, Sharon A Savage, Xiaohong R Yang, Christopher Amos, Maria Teresa Landi

    Published in PLoS ONE (2012-01-01)
    Get full text
    Article


  6. 6

    Identifying therapeutic targets for cancer among 2074 circulating proteins and risk of nine cancers by Karl Smith-Byrne, Åsa Hedman, Marios Dimitriou, Trishna Desai, Alexandr V. Sokolov, Helgi B. Schioth, Mine Koprulu, Maik Pietzner, Claudia Langenberg, Joshua Atkins, Ricardo Cortez Penha, James McKay, Paul Brennan, Sirui Zhou, Brent J. Richards, James Yarmolinsky, Richard M. Martin, Joana Borlido, Xinmeng J. Mu, Adam Butterworth, Xia Shen, Jim Wilson, Themistocles L. Assimes, Rayjean J. Hung, Christopher Amos, Mark Purdue, Nathaniel Rothman, Stephen Chanock, Ruth C. Travis, Mattias Johansson, Anders Mälarstig

    Published in Nature Communications (2024-04-01)
    Get full text
    Article


Search Tools: